Navigation Links
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results
Date:2/11/2010

SHENYANG, China, Feb. 11 /PRNewswire-Asia/ -- 3SBio Inc. ( SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2009.

    Full Year 2009 Financial Highlights:
    -- Total net revenues in 2009 increased by 30.3% year-over-year to
       RMB316.9 million (US$46.4 million) compared to RMB243.2 million
       (US$35.7 million) in 2008.
    -- Non-GAAP operating income in 2009 increased by 52.3% year-over-year to
       RMB90.9 million (US$13.3 million) and GAAP operating income increased
       by 76.6% to RMB84.4 million (US$12.4 million).
    -- Non-GAAP net income in 2009 increased by 20.3% year-over-year to
       RMB90.3 million (US$13.2 million). GAAP net income increased by 111.0%
       year-over-year to RMB83.4 million (US$12.2 million).
    -- Non-GAAP net income per American Depositary Share (ADS) on a
       fully-diluted basis in 2009 was RMB4.18 (US$0.61) compared with RMB3.46
       (US$0.51) in 2008. GAAP net income per ADS on a fully-diluted basis in
       2009 was RMB3.87 (US$0.57) compared with RMB1.82 (US$0.27) in 2008.


    Fourth Quarter 2009 Financial Highlights:
    -- Total net revenues increased by 23.7% over the fourth quarter of 2008
       to RMB74.3 million (US$10.9 million).
    -- Non-GAAP operating income was RMB13.5 million (US$2.0 million), an
       increase of RMB7.4 million (US$1.1 million) over the fourth quarter of
       2008. GAAP operating income was RMB9.9 million (US$1.5 million),
       compared to an operating loss of RMB2.3 million (US$0.3 million) in the
       fourth quarter of 2008.
    -- Non-GAAP net income was RMB14.4 m
'/>"/>
SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
2. 3SBio Inc. to Hold Annual General Meeting
3. 3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007
4. 3SBio Inc. To Present at the 19th Annual Piper Jaffray Health Care Conference
5. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
6. 3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. 3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
8. 3SBio Inc. Announces Change to the Board of Directors
9. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
10. 3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer
11. 3SBio Inc. Approves Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... ... managed with the use of special anti-vascular endothelial growth factor agents given by ... patients, currently does not have a scientific protocol for the many millions diagnosed ...
(Date:9/2/2015)... 2, 2015 Biovista Inc. is ... the 2015 BeHEARD science challenge, a global competition hosted ... researchers, access to the latest life science innovations and ... and pathway analytics capability to support Steven Laffoon ... the study of Niemann-Pick Disease Type A (NPA), a ...
(Date:9/2/2015)... , Sept. 2, 2015 Aytu BioScience, ... developing treatments for urological and related conditions, announced today ... planned private placement convertible note financing, raising a total ... tranches totaling $3.175 million. Josh ... from this private placement are intended to be used ...
(Date:9/2/2015)... , September 2, 2015 ... des Wettbewerbs BeHEARD von 2015 bekanntgeben zu können. ... Rare Genomics Institute. Biovista unterstützt mit ... für die Behandlung anderer Krankheiten als denen, für ... Laffoon und sein Team bei der Wylder ...
Breaking Biology Technology:StemCell GeneticMed Announces That It Has Started Stem Cell Treatments for Age Related Dry Macular Degeneration (AMG) 2Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2
... Health, Labor and Welfare (MHLW), for the revolutionary medical ... ... blood, IRVINE, Calif., Nov. 27 Masimo, the inventor,of ... announced approval of the Masimo Rad-57 Pulse CO-Oximeter,bringing the world,s ...
... Research &,Instrumentation, Inc. (CRi) announces the launch of ... Maestro 2 received widespread acclaim,at the both the ... conference for in vivo imaging, and at the ... 2, the fully,automated version of the award-winning Maestro ...
... 26 Pharmacopeia,(Nasdaq: PCOP ), an innovator in ... announced that Dr. Leslie J. Browne,President and Chief Executive ... Focus on Healthcare Conference hosted by,BMO Capital Markets. The ... Broadway Hotel in New York City., Dr. Browne,s ...
Cached Biology Technology:Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan 2Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan 3Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan 4CRi Announces Maestro 2, the Next Generation in Vivo Optical Imaging Systems 2Pharmacopeia To Present at BMO Capital Markets' Seventh Annual Focus on Healthcare Conference 2Pharmacopeia To Present at BMO Capital Markets' Seventh Annual Focus on Healthcare Conference 3
(Date:8/4/2015)... , Aug. 04, 2015 ... ) has announced the addition of the ... Software, and Service), Sub-Segment (Computer Forensics, Network ... Tool Types, Service, Vertical and Region - ... their offering. By Component (Hardware, ...
(Date:7/31/2015)... -- Den 10. internationale konference om Genomik (ICG-10, ... 25. oktober i Shenzhen , Kina. ... år. Siden starten i 2006 er ICB blevet en ... er en af de mest dynamiske, entusiastiske og sjove ... gennembrud og fremskridt inden for ,omik,-forskning, som yderligere vil ...
(Date:7/31/2015)... Chine, 31 juillet 2015 La 10e ... ) sera organisée par le BGI du 22 ... en Chine. La conférence ... inauguration en 2006, l,ICG est devenue l,une des ... domaine des « omiques » et c,est aussi la plus ...
Breaking Biology News(10 mins):Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3
... School (HMS) report in the April 23 issue of ... values that subjects assign to different items. The activity ... that occurs when someone chooses between different goods. , ... parts of the brain respond to separate attributes, such ...
... in half by 2015. That commitment is now looking like an ... a Cornell University expert on world hunger. , If business proceeds ... world -- 800 million -- in 2015 as there were 16 ... and Public Policy and the 2001 Food Prize laureate. He will ...
... University of Toronto have designed a nanoscale assembly ... toxin in animal and laboratory experiments. The novel ... applied in designing potent therapeutics for a variety ... , Anthrax toxin, secreted by the anthrax bacterium, ...
Cached Biology News:Attention shoppers: Researchers find neurons that encode the value of different goods 2Attention shoppers: Researchers find neurons that encode the value of different goods 3World's pledge to halve hunger by 2015 looks like empty promise 2Anthrax inhibitor counteracts toxin, may lead to new therapeutics 2Anthrax inhibitor counteracts toxin, may lead to new therapeutics 3
... nucleic acid gel stain has bright fluorescence when ... making it ideal for detecting dsDNA in gels ... SYBR Green I nucleic acid stain has ... PCR assays and bandshift assays. A 500 µL ...
... McCoy and his coworkers reported ... in vitro cultivation of Novikoff ... performed using,Basal Medium 5A and ... new medium known as McCoy's ...
Eagle's Ham's amino acids; EHAA...
... in Molecular Probes. SlowFadeAntifade Kits is ... as a free radical scavenger that ... SlowFade formulation (S-2828) was designed to ... to almost zero (Figure 1); it ...
Biology Products: